Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to research

Neratinib in HER2-Positive Breast Cancer Patients

201930 citationsJournal Article

Authors

Rutugandha Paranjpe · University of Houston

Dima Basatneh · University of Houston

Gabriel Tao · University of Houston

Carmine De Angelis

Sobia Noormohammed · University of Houston

Ekim Ekinci · Methodist Hospital

Susan Abughosh · University of Houston

Abstract

Neratinib significantly improves treatment outcomes and has manageable toxicity in stage I to III HER2+ BC patients.

Topics & Keywords

HER2/EGFR in Cancer Research Chronic Lymphocytic Leukemia Research Advanced Breast Cancer Therapies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Pharmacotherapy

Volume 53, Issue 6, pp. 612-620

DOI: 10.1177/1060028018824088

Field-Weighted Citation Impact: 2.12

Neratinib in HER2-Positive Breast Cancer Patients | Researchclopedia

· University of Houston

Meghana V. Trivedi · University of Houston